- $80.28m
- -$102.55m
- $0.32m
- 29
- 26
- 55
- 30
Annual cashflow statement for Chimerix, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -113 | -43.5 | -173 | 172 | -82.1 |
| Depreciation | |||||
| Non-Cash Items | 42.8 | 5.35 | 56.9 | -216 | 10.5 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -5.97 | 1.73 | 16.3 | -3.42 | 2.42 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Payable / Accrued Expenses | |||||
| Cash from Operating Activities | -75.2 | -36 | -99.9 | -46.9 | -69.1 |
| Capital Expenditures | -0.158 | -0.058 | -0.207 | -0.071 | -0.089 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 10.8 | 64.8 | -43.9 | 70.1 | 70.7 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | 10.6 | 64.7 | -44.1 | 70 | 70.6 |
| Financing Cash Flow Items | 0.302 | 0.426 | 109 | 0.667 | 0.308 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0.345 | 1.41 | 112 | -12.7 | 0.308 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -64.2 | 30.1 | -31.6 | 10.4 | 1.82 |